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Material and Methods: An oropharynx cancer patient 
included in the ARTFIBIO project with a swollen node was 
selected. The pre-treatment imaging protocol was: MRI 
(DWMRI, DCEMRI) and PET/CT with FDG. Geometric distortion 
of DWMRI was corrected using the reversed gradient method 
(RGM) and the SPM8 software. DCEMRI analyses were 
performed using Dynamika® v4.0 
(www.imageanalysis.org.uk). All the datasets were registered 
using ARTFIBio tools. 
The parameters for classifying subvolumes were (Figure A): 
Initial Rate Enhancement (IRE) from DCEMRI, that measures 
the initial slope of gadolinium concentration and related to 
vascularization, Apparent Diffusion Coefficient (ADC) from 
DWMRI, previously corrected by the RGM, related to tumour 
density, and SUV from PET/CT with FDG. Thus, three 
subvolumes have been delimited: node, hypoxic volume (low 
IRE) and necrotic volume (red region in DWMRI b0, high ADC, 
very low IRE). 
 
Results: We have analysed the relationship between the 
three selected parameters (ADC, IRE and SUV) for the whole 
node and for the badly vascularized region excluding the 
necrotic region. When we considered the whole node (Figure 
B), we observe a complex relationship between these three 
parameters, but when we only consider the badly 
vascularized region (low IRE, low ADC), we observe a clear 
relationship between these parameters, that suggest that 
vascularization quantified by IRE must be related to 
oxygenation, as lowest vascularized dots (blue dots, figure 
C), correspond to high SUV for the same ADC, indicating an 
enhancement of the Pasteur effect in the badly vascularized 
region. 
 
 
 
Conclusion: Several functional imaging techniques can be 
required to customize treatment, but an appropriate 
registration process must be applied. ADC maps can be used 
for tumour cell quantification, but distortion correction 
algorithm must be previously applied, RGM looks quite 
suitable. Oxygenation process can be estimated from DCEMRI 
in head and neck cancer, as vascularization is related to 
oxygenation in these cancers, and as our results suggest. 
PET/CT and MRI studies provide information about 
malignancy grade of the tumour, considering glucose 
metabolism, tumour cell density (from ADC maps) and 
oxygenation (DCEMRI).  
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Purpose or Objective: Identification of outcome predictive 
factors at an early stage of radiation therapy allows for 
adaptation and individualisation. Such predictive factors are 
crucial for advanced head and neck (H&N) cancer patients 
since the treatment failure is often caused by poor loco-
regional control. An early treatment adaptation would allow 
a dose escalation in the most radioresistant tumour regions. 
The aim of this study was to early identify sub-regions in H&N 
tumours non-responding to the treatment. This was achieved 
by applying a previously developed method using [18F]-
fluorodeoxy-D-glucose positron emission tomography (FDG 
PET) to evaluate the early responsiveness of lung tumours. 
 
Material and Methods: Thirteen patients with advanced H&N 
cancer were imaged with FDG PET before the start and 
during the second week of concurrent chemoradiotherapy 
(after about 19 Gy of delivered dose to the primary gross 
tumour volume, GTVprim). The acquired PET images were co-
registered to the planning CT and a systematic analysis was 
performed to calculate an operational parameter at voxel 
level, the effective radiosensitivity αeff which accounts for 
the accumulated dose distribution at the time of the second 
PET scan and variations in the FDG uptake. Volumetric maps 
of αeff values within GTVprim, as well as the average 
(a_αeff) and negative fractions (nf_αeff) of αeff values were 
determined. Patients were stratified in responders and non-
responders to treatment based on previously determined 
criteria for overall survival at 2 years for concurrent 
chemoradiotherapy in lung cancer (a_αeff>0.004 Gy-1 and 
nf_αeff≤30%). The spatial distribution of the αeff values was 
mapped for the non-responders to treatment for future 
adaptation strategies. 
 
Results: The previously proposed method was feasible for 
H&N cancer patients and predicted good response in 54% of 
the patients having simultaneously a_αeff>0.004 Gy-1 and 
nf_αeff≤30%. Figure 1a shows an example of the effective 
radiosensitivity map for a selected slice of the GTVprim in 
one of the H&N cancer patients. The corresponding binary 
image with threshold on the negative portion of the αeff 
distribution is presented in Figure 1b (white: αeff>0; black: 
αeff<0). Calculated volumetric maps of the effective 
radiosensitivity values showed that it was possible to segment 
confined sub-regions in the tumour which might indicate 
resistance to the treatment (Figure 1b).  
 
Conclusion: Confined tumour sub-regions showing lack of 
metabolic response which might correlate to resistance to 
treatment could be identified at an early stage during the 
radiotherapy regime. Investigations on different dose 
boosting strategies are on-going to account for the 
quantitative information available from the αeff volumetric 
maps.  
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Purpose or Objective: Patients suffering from high-grade 
gliomas currently have a median survival time of 14 months 
despite treatment. Our purpose was to investigate whether 
MR perfusion and relative Cerebral Blood Volume (rCBV) maps 
could predict tumor recurrence areas and improve treatment 
planning. 
 
Material and Methods: This retrospective study included 19 
patients suffering from high grade gliomas (3 and 4) who 
received standard radiotherapy [60 Gy, 2 Gy/fraction] and 
Temodal chemotherapy. Subjects underwent pre-treatment 
CT, gadolinium-enhanced T1-weighted, T2 FLAIR acquisitions 
and a DSC-MR scan. rCBV maps were calculated using READE 
View Advantage Workstation (GE) and normalized to the 
normal white matter perfusion value. The PLANET software 
(DOSIsoft) was used to register all MR images to the planning 
CT. A senior radiologist and a senior radiotherapist 
delineated Gross Tumor Volumes (GTV) on anatomical MR 
images. The Planning Target Volumes (PTV) were defined by 
a physicist. Threshold of 1.7 was applied to the rCBV maps to 
define hyper-perfused volumes (Vperf). Follow-up anatomical 
MR images were used to localize recurrence areas (GTV’). 
Correlations between all volumes were analyzed using several 
indexes. I1 is the percentage of Vperf not included in the 
GTV. I2, I3, and I5 are respectively the percentage of GTV’ 
included in Vperf, GTV, and PTV. I4 is the percentage of 
Vperf’ not included in the GTV which was predictive of tumor 
recurrence outside GTV. This index is meaningful only if GTV’ 
and GVT are different.  
 
Results: Indexes obtained for each patient are presented in 
Table 1. For two patients, a threshold of 2 was applied to the 
rCBV maps at the physician request to facilitate the hyper-
perfused area visualization. I1 values are in a range of 4 to 
82% (mean = 43%) and are greater than 20% for almost 90% of 
the patients, indicating that hyper-perfused areas and GTV 
can be different. Hence, rCBV maps provide supplementary 
information. At least 40% of GTV’ is included in Vperf for 16 
patients (I2 index). For 10 patients, GTV’ is not completely 
included in the GTV (I3 < 85%). In all these cases except one, 
the I4 index is greater than 20%, suggesting that a part of 
Vperf is predictive of the recurrence localization (Figure 1). 
I5 being almost always equal to 1 points out that all 
recurrence areas received the same dose as the GTV.  
 
 
 
 
Conclusion: Our results suggest that rCBV perfusion maps can 
be predictive of recurrence localization. I1, I2 and I4 values 
are however entirely dependent on the threshold applied to 
rCBV maps and their evolution while the threshold increases 
will be studied. As recurrence areas are always included in 
the PTV, an improvement of treatment planning would 
consist in boosting hyper-perfused area rather than changing 
the GTV delineation. An in-depth analysis of the pre-
treatment rCBV values observed in recurrence areas will be 
conducted to better describe potential boost areas.  
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